Forum Financial Management LP Boosts Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Forum Financial Management LP boosted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 25.2% in the 4th quarter, Holdings Channel reports. The fund owned 8,480 shares of the healthcare conglomerate’s stock after buying an additional 1,709 shares during the period. Forum Financial Management LP’s holdings in UnitedHealth Group were worth $4,290,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also made changes to their positions in UNH. Frederick Financial Consultants LLC purchased a new position in UnitedHealth Group during the fourth quarter valued at $271,000. Commerce Bank boosted its stake in UnitedHealth Group by 1.1% during the 4th quarter. Commerce Bank now owns 120,415 shares of the healthcare conglomerate’s stock worth $60,913,000 after purchasing an additional 1,316 shares during the last quarter. Capital International Investors boosted its position in UnitedHealth Group by 6.2% during the fourth quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate’s stock worth $7,899,905,000 after acquiring an additional 906,365 shares during the last quarter. Allred Capital Management LLC boosted its holdings in shares of UnitedHealth Group by 1.5% during the 4th quarter. Allred Capital Management LLC now owns 2,648 shares of the healthcare conglomerate’s stock worth $1,340,000 after purchasing an additional 40 shares during the last quarter. Finally, Alpha DNA Investment Management LLC lifted its position in UnitedHealth Group by 3.4% during the fourth quarter. Alpha DNA Investment Management LLC now owns 3,411 shares of the healthcare conglomerate’s stock worth $1,725,000 after buying an additional 111 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

UNH has been the subject of several analyst reports. Mizuho increased their price target on shares of UnitedHealth Group from $600.00 to $650.00 and gave the company an “outperform” rating in a research note on Wednesday, April 9th. Barclays dropped their price target on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research report on Friday, January 17th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $700.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. Piper Sandler reduced their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research report on Thursday, January 2nd. Finally, KeyCorp restated an “overweight” rating and issued a $650.00 price target on shares of UnitedHealth Group in a research note on Friday, January 17th. Twenty-one equities research analysts have rated the stock with a buy rating and three have issued a strong buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Buy” and a consensus target price of $632.85.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $456.10 on Friday. The business has a fifty day moving average of $514.51 and a two-hundred day moving average of $541.53. UnitedHealth Group Incorporated has a one year low of $438.50 and a one year high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The company has a market cap of $417.20 billion, a P/E ratio of 29.43, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $109.58 billion during the quarter, compared to analysts’ expectations of $111.56 billion. During the same quarter in the prior year, the business earned $6.91 EPS. As a group, analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were given a dividend of $2.10 per share. The ex-dividend date was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 1.84%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 54.19%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.